Literature DB >> 30302221

The influence of antiretroviral therapy on clinical aspects of HIV-related lymphoma.

José-Tomás Navarro1, Josep-Maria Ribera1.   

Abstract

Entities:  

Year:  2017        PMID： 30302221      PMCID： PMC6171968          DOI： 10.2217/ijh-2017-0017

Source DB:  PubMed          Journal:  Int J Hematol Oncol        ISSN： 2045-1393


× No keyword cloud information.
  19 in total

Review 1.  The biology and treatment of plasmablastic lymphoma.

Authors:  Jorge J Castillo; Michele Bibas; Roberto N Miranda
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

2.  Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.

Authors:  Jorge J Castillo; Mark Bower; Jérémy Brühlmann; Urban Novak; Hansjakob Furrer; Paula Y Tanaka; Caroline Besson; Silvia Montoto; Kate Cwynarski; Jeremy S Abramson; Samir Dalia; Michele Bibas; Joseph M Connors; Michael Furman; Minh-Ly Nguyen; Timothy P Cooley; Brady E Beltran; Jaime A Collins; Julie M Vose; Blanca Xicoy; Josep-Maria Ribera
Journal:  Cancer       Date:  2014-09-23       Impact factor: 6.860

Review 3.  Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.

Authors:  Stefan K Barta; Xiaonan Xue; Dan Wang; Roni Tamari; Jeannette Y Lee; Nicolas Mounier; Lawrence D Kaplan; Josep-Maria Ribera; Michele Spina; Umberto Tirelli; Rudolf Weiss; Lionel Galicier; Francois Boue; Wyndham H Wilson; Christoph Wyen; Albert Oriol; José-Tomás Navarro; Kieron Dunleavy; Richard F Little; Lee Ratner; Olga Garcia; Mireia Morgades; Scot C Remick; Ariela Noy; Joseph A Sparano
Journal:  Blood       Date:  2013-09-06       Impact factor: 22.113

4.  HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era.

Authors:  Maria Joao Baptista; Olga Garcia; Mireia Morgades; Eva Gonzalez-Barca; Pilar Miralles; Armando Lopez-Guillermo; Eugenia Abella; Miriam Moreno; Juan-Manuel Sancho; Evarist Feliu; Josep-Maria Ribera; Jose-Tomas Navarro
Journal:  AIDS       Date:  2015-04-24       Impact factor: 4.177

5.  Excellent immunological recovery following CODOX-M/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma.

Authors:  Silvia Montoto; Jamie Wilson; Kate Shaw; Maureen Heath; Andy Wilson; Christopher McNamara; Chloe Orkin; Mark Nelson; Margaret Johnson; Mark Bower; Kate Cwynarski
Journal:  AIDS       Date:  2010-03-27       Impact factor: 4.177

6.  HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.

Authors:  Silvia Montoto; Kate Shaw; Jessica Okosun; Shreyans Gandhi; Paul Fields; Andrew Wilson; Milensu Shanyinde; Kate Cwynarski; Robert Marcus; Johannes de Vos; Anna Marie Young; Melinda Tenant-Flowers; Chloe Orkin; Margaret Johnson; Daniella Chilton; John G Gribben; Mark Bower
Journal:  J Clin Oncol       Date:  2012-10-08       Impact factor: 44.544

7.  Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort.

Authors:  Mira Hleyhel; Aurélien Belot; Anne Marie Bouvier; Pierre Tattevin; Jérôme Pacanowski; Philippe Genet; Nathalie De Castro; Jean-Luc Berger; Caroline Dupont; Armelle Lavolé; Christian Pradier; Dominique Salmon; Anne Simon; Valérie Martinez; Dominique Costagliola; Sophie Grabar
Journal:  Clin Infect Dis       Date:  2013-07-29       Impact factor: 9.079

8.  Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.

Authors:  Satish Gopal; Monita R Patel; Elizabeth L Yanik; Stephen R Cole; Chad J Achenbach; Sonia Napravnik; Greer A Burkholder; Erin G Reid; Benigno Rodriguez; Steven G Deeks; Kenneth H Mayer; Richard D Moore; Mari M Kitahata; Joseph J Eron; Kristy L Richards
Journal:  J Natl Cancer Inst       Date:  2013-07-26       Impact factor: 13.506

9.  Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000.

Authors:  Marie-Anne Vandenhende; Caroline Roussillon; Sandrine Henard; Philippe Morlat; Eric Oksenhendler; Hugues Aumaitre; Aurore Georget; Thierry May; Eric Rosenthal; Dominique Salmon; Patrice Cacoub; Dominique Costagliola; Geneviève Chêne; Fabrice Bonnet
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

10.  Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011.

Authors:  Elizabeth L Yanik; Kristen Tamburro; Joseph J Eron; Blossom Damania; Sonia Napravnik; Dirk P Dittmer
Journal:  Infect Agent Cancer       Date:  2013-05-24       Impact factor: 2.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.